Business & Finance
Olympus Shares Plunge After FDA Warning Letter on Six Facilities
Key Points
Health Olympus Shares Plunge After FDA Warning Letter on Six Facilities Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities. The company’s stock slumped as much as 17% in Tokyo. The letter relates to quality management system and process observations made after inspections conducted in late 2025, Olympus said in a...
Health
Olympus Shares Plunge After FDA Warning Letter on Six Facilities
Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities.
The company’s stock slumped as much as 17% in Tokyo. The letter relates to quality management system and process observations made after inspections conducted in late 2025, Olympus said in a filing Tuesday. The warning will not disrupt production and its not expected to impact financial results, it said.